These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9043663)

  • 21. [Inhibitors of isoprenylation of ras p21].
    Yoshimatsu K
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1495-502. PubMed ID: 9309147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of pseudopeptides inhibitors of Ras farnesyl transferase containing unconventional amino acids.
    Caliendo G; Fiorino F; Grieco P; Perissutti E; De Luca S; Giuliano A; Santelli G; Califano D; Severino B; Santagada V
    Farmaco; 1999; 54(11-12):785-90. PubMed ID: 10668180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,8-Diazabicyclo[3.2.1]octan-2-one peptide mimetics: synthesis of a conformationally restricted inhibitor of farnesyltransferase.
    Dinsmore CJ; Bergman JM; Bogusky MJ; Culberson JC; Hamilton KA; Graham SL
    Org Lett; 2001 Mar; 3(6):865-8. PubMed ID: 11263902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereospecific synthesis of a novel farnesyl protein transferase inhibitor, valinoctin A and its analogues.
    Tsuda M; Muraoka Y; Takeuchi T; Sekizawa R; Umezawa K
    J Antibiot (Tokyo); 1996 Oct; 49(10):1031-5. PubMed ID: 8968397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferase.
    Njoroge FG; Doll RJ; Vibulbhan B; Alvarez CS; Bishop WR; Petrin J; Kirschmeier P; Carruthers NI; Wong JK; Albanese MM; Piwinski JJ; Catino J; Girijavallabhan V; Ganguly AK
    Bioorg Med Chem; 1997 Jan; 5(1):101-13. PubMed ID: 9043662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
    Williams TM; Ciccarone TM; MacTough SC; Bock RL; Conner MW; Davide JP; Hamilton K; Koblan KS; Kohl NE; Kral AM; Mosser SD; Omer CA; Pompliano DL; Rands E; Schaber MD; Shah D; Wilson FR; Gibbs JB; Graham SL; Hartman GD; Oliff AI; Smith RL
    J Med Chem; 1996 Mar; 39(7):1345-8. PubMed ID: 8691462
    [No Abstract]   [Full Text] [Related]  

  • 28. Benzodiazepine peptidomimetic inhibitors of farnesyltransferase.
    Marsters JC; McDowell RS; Reynolds ME; Oare DA; Somers TC; Stanley MS; Rawson TE; Struble ME; Burdick DJ; Chan KS
    Bioorg Med Chem; 1994 Sep; 2(9):949-57. PubMed ID: 7712130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.
    Leonard DM; Shuler KR; Poulter CJ; Eaton SR; Sawyer TK; Hodges JC; Su TZ; Scholten JD; Gowan RC; Sebolt-Leopold JS; Doherty AM
    J Med Chem; 1997 Jan; 40(2):192-200. PubMed ID: 9003517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Aminopyrrolidinone farnesyltransferase inhibitors: design of macrocyclic compounds with improved pharmacokinetics and excellent cell potency.
    Bell IM; Gallicchio SN; Abrams M; Beese LS; Beshore DC; Bhimnathwala H; Bogusky MJ; Buser CA; Culberson JC; Davide J; Ellis-Hutchings M; Fernandes C; Gibbs JB; Graham SL; Hamilton KA; Hartman GD; Heimbrook DC; Homnick CF; Huber HE; Huff JR; Kassahun K; Koblan KS; Kohl NE; Lobell RB; Lynch JJ; Robinson R; Rodrigues AD; Taylor JS; Walsh ES; Williams TM; Zartman CB
    J Med Chem; 2002 Jun; 45(12):2388-409. PubMed ID: 12036349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple and efficient synthesis of the ras farnesyl-protein transferase inhibitor chaetomellic acid A.
    Argade NP; Naik RH
    Bioorg Med Chem; 1996 Jun; 4(6):881-3. PubMed ID: 8818238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.
    Henry KJ; Wasicak J; Tasker AS; Cohen J; Ewing P; Mitten M; Larsen JJ; Kalvin DM; Swenson R; Ng SC; Saeed B; Cherian S; Sham H; Rosenberg SH
    J Med Chem; 1999 Nov; 42(23):4844-52. PubMed ID: 10579847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-thiol farnesyltransferase inhibitors: evaluation of different AA(X)-peptidomimetic substructures in combination with arylic cysteine replacements.
    Sakowski J; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2002 Apr; 335(4):135-42. PubMed ID: 12112033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential of farnesyltransferase inhibitors as cancer chemotherapeutics.
    Gibbs JB; Oliff A
    Annu Rev Pharmacol Toxicol; 1997; 37():143-66. PubMed ID: 9131250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein farnesyltransferase inhibitors.
    Ayral-Kaloustian S; Salaski EJ
    Curr Med Chem; 2002 May; 9(10):1003-32. PubMed ID: 12733981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel and selective imidazole-containing biphenyl inhibitors of protein farnesyltransferase.
    Curtin ML; Florjancic AS; Cohen J; Gu WZ; Frost DJ; Muchmore SW; Sham HL
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1367-71. PubMed ID: 12657284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor.
    Kohl NE; Mosser SD; deSolms SJ; Giuliani EA; Pompliano DL; Graham SL; Smith RL; Scolnick EM; Oliff A; Gibbs JB
    Science; 1993 Jun; 260(5116):1934-7. PubMed ID: 8316833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of some hydroxyproline-derived peptidomimetics as isoprenyltransferase inhibitors.
    O'Connell CE; Rowell CA; Ackermann K; Garcia AM; Lewis MD; Kowalczyk JJ
    Chem Pharm Bull (Tokyo); 2000 May; 48(5):740-2. PubMed ID: 10823715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.